Mini-BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCL-Reference-Cited by-同舟云学术

Mini-BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCL

Published:2012-03-20 Issue:5 Volume:157 Page:543-552
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Moore Sally¹,Kayani Irfan²,Peggs Karl¹,Qian Wendi³,Lowry Lisa¹,Thomson Kirsty¹,Linch David C.¹,Ardeshna Kirit¹

Affiliation:

1. Department of Haematology; University College Hospital; London; UK

2. Department of Nuclear Medicine; University College Hospital; London; UK

3. Medical Research Department; MRC Centre; London; UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2012.09096.x/fullpdf

Reference35 articles.

1. Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen;Anderlini;Bone Marrow Transplantation,2005

2. Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens;Ardeshna;British Journal of Haematology,2005

3. Identification factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease;Canales;Haematologica,2001

4. Results from a pivotal phase II study of brentuximab vedotin (SGN-35) in patients with relapsed or refractory Hodgkin lymphoma (HL);Chen;Journal of Clinical Oncology,2011

5. Revised response criteria for malignant lymphoma;Cheson;Journal of Clinical Oncology,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability;Oncotarget;2023-12-12

2. Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma;JAMA Network Open;2020-04-06

3. Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels;Journal of Clinical Oncology;2017-06-01

4. Guidelines for the management of diffuse large B-cell lymphoma;British Journal of Haematology;2016-05-16

5. Pharmacologic Basis for High-dose Chemotherapy;Thomas’ Hematopoietic Cell Transplantation;2016-01-01